Category: Infectious Diseases
Adimora Recognized for Contributions to COVID-19 Treatment Guidelines
Adaora A. Adimora, MD, MPH National Institutes of Health (NIH) Director Francis S. Collins, MD, PhD, and National Institute of Allergy and Infectious Diseases Director Anthony Fauci, MD, recognized Ada Adimora, MD, MPH, on Dec. 8 for her contributions to the NIH’s COVID-19 Treatment Guidelines. “As you well know, it has been quite a task to assemble a panel representing so many d … Read more
Cohen, Wohl and Weber Answer Questions About Omicron Urging Individuals to Get Vaccinated
Experts in infectious diseases talked with media about the omicron variant and continued to urge individuals to be vaccinated. Following is a list of articles featuring faculty in the Department of Medicine during the week of December 10-16. David Weber, MD, MPH Can current monoclonal antibodies protect against the omicron variant? – Dr. Myron Cohen (WSOC-TV) UNC infectious disea … Read more
Newsworthy From the Department of Medicine, Week of December 3 – 9, featuring Dr. David Wohl
David Wohl, MD Following is a listing of news stories featuring UNC Department of Medicine faculty during the past week, starting Friday December 3, 2021. ‘No one is safe until everyone is safe’: Vaccination numbers across the world need to improve to beat COVID – Dr. David Wohl (CBS17) Why did the COVID numbers jump in N.C. last week? – Dr. David Wohl (Spectrum News) Hospitals f … Read more
-
What We Know–And Don’t Know–About the Omicron Variant
David Wohl, MD Thanksgiving merriment was tempered with news of the new omicron COVID-19 variant, which was first detected in South Africa and found quickly in more than 20 countries. This has raised concerns among scientists and healthcare providers who were hoping to bring the pandemic under control in the coming months. Infectious diseases specialist David A. Wohl, MD, explain … Read more
UNC Health in the News: Experts Discuss the Omicron Variant
Myron Cohen, MD UNC Health and School of Medicine experts from the division of infectious diseases were featured in media outlets nationwide discussing the recently identified omicron variant of the COVID-19 virus. UNC expert says much to understand about omicron variant, featuring Dr. Myron Cohen (ABC 11) When is omicron COVID variant coming to North Carolina?, featuring Dr. Da … Read more
Newsworthy From the Department of Medicine, Week of November 29 – December 2
Emily Sickbert-Bennett, PhD, MS UNC researchers working to learn more about omicron variant as 1st case is identified in US – Drs. Melissa Miller and David Wohl (CBS 17) Worried about omicron? COVID’s delta strain remains a bigger threat, UNC doctors say – Drs. Melissa Miller and David Wohl (Charlotte Observer) COVID-19 Mask Recommendations Open New Chapter in Cover Story – Dr. E … Read more
Welcome to our 2022-2023 ID fellows!
We are excited to announce that we have matched 4 physicians to the ID Fellowship for the 2022-2023 academic year! Drs. Briana Castillo, Alex Commanday, John Franzone, and Stephanie Sweitzer will be joining UNC in July. Briana Castillo, MD Interests: HIV, HCV, LGBTQIA+ health, and substance use Residency: University of Illinois Chicago Alex Commanday, MD Interests: Domestic HIV i … Read more
Garcia Named Diversity Speaker Award Recipient
Victor Garcia-Martinez, PhD Victor Garcia, PhD, was named the 2022 recipient of the International Society for Antiviral Research Diversity Speaker Award. UNC School of Medicine’s Craig Cameron, PhD, received the society’s inaugural award for 2021. Last year, the International Society for Antiviral Research (ISAR) created the Diversity Speaker Award to recognize an outstanding sci … Read more
Department of Medicine Grants & Funding: November 1 – November 30, 2021
Division of Cardiology Bristol Myers Squibb Foundation has awarded Anil Gehi, MD, a three-year grant to improve atrial fibrillation (AF) care. Division of General Medicine and Clinical Epidemiology Seth Berkowitz, MD, received an R01 NIH grant to advance health equity in Type 2 diabetes. Division of Infectious Diseases David Rosen, MD, PhD, is principal investigator of a study th … Read more
Rutstein awarded NC TraCS pilot grant for characterizing long-acting injectable antiretroviral therapy
Sarah Rutstein, MD, PhD Third year ID fellow Sarah Rutstein, MD, PhD (co-I Farel, Go, Napravnik) was awarded a $50K pilot grant from the North Carolina Translational and Clinical Sciences Institute (NC TraCS). NC TraCS supports and funds translational research to improve the health of North Carolina communities. The institute’s Translational Research Matched Pilot Program encoura … Read more
-
Phase 3 Data Show Monoclonal Antibodies Provide long-term Protection Against COVID-19
A single dose of REGEN-COV, a combination monoclonal antibody therapy, reduced the risk of COVID-19 by 81.6% several months after a single dose. UNC School of Medicine’s Myron Cohen, MD, leads monoclonal antibody research efforts as part of the NIH-sponsored COVID Prevention Network. Myron Cohen, MD Regeneron Pharmaceuticals, Inc. announced additional positive results from a phas … Read more
Newsworthy from the Department of Medicine, Week of November 5 – 11
The below clickable headlines link directly to outside media outlets and feature Department of Medicine faculty during the past week, starting Friday, November 5, 2021. Laura Young, MD COVID-19 treatments are not vaccine replacements. Here’s why – Dr. David Wohl (ArcaMax Publishing) Is Type 2 Diabetes Ready for CGM? – Dr. Laura Young (The Journal of Healthcare Contracting) 10 gas … Read more